D'PULA MEDICAL SOLUTIONS
LIVE

Serial Number

88907215

Owner

D'Pula Medical Solutions Corporation

Attorney

Jonathan Brown

Filing Date

May 8, 2020

Add to watchlist:

No watchlists yet
View on USPTO

D'PULA MEDICAL SOLUTIONS Trademark

Serial Number: 88907215 • Registration: 6932929

D'PULA MEDICAL SOLUTIONS is a trademark filed by D'Pula Medical Solutions Corporation on May 8, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

D'Pula Medical Solutions Corporation (2 trademarks)

Onoedori, Chou-Ku, Kobe-Shi
Hyogo 651-0088 , JP

Entity Type: 03

SYSMEX CORPORATION (184 trademarks)

1-5-1 WAKINOHAMA-KAIGANDORI
CHUO-KU, KOBE , JP

Entity Type: 03

Trademark Details

Filing Date

May 8, 2020

Registration Date

December 27, 2022

Published for Opposition

October 11, 2022

Goods & Services

Recorded and downloadable computer software platforms for executing medical application software, namely, for providing of medical information to medical organizations, potential patients, patients or medical professionals; Downloadable computer application software for providing of medical information to medical organizations, medical providers, potential patients, patients or medical professionals; Downloadable computer application software for medical treatment, namely, for digital therapeutics; Downloadable computer application software for medical testing and diagnostics

Business consultancy services; Providing business information; Business consultancy services relating to pharmaceutical application in the nature of regulatory submission management, namely, assisting others in preparing or filing applications for regulatory approval of pharmaceuticals, medical devices or medical software; Providing business information relating to pharmaceutical application, namely, information on regulatory submission management regarding the preparation or filing of applications for regulatory approval of pharmaceuticals, medical devices or medical software as it relates to business; Business consultancy services in the field of pharmaceuticals; Providing business information in the field of pharmaceuticals

Regulatory compliance consulting in the field of assisting others in preparing or filing pharmaceutical applications for regulatory approval of pharmaceuticals, medical devices or medical software

Platform as a service (PaaS) featuring computer software platforms for executing medical application software, namely, for providing of medical information to medical organizations, medical providers, potential patients, patients or medical professionals; Design, development and maintenance of computer software platforms; Providing temporary use of online non-downloadable computer software for providing of medical information to medical organizations, medical providers, potential patients, patients or medical professionals; Design, development and maintenance of computer application software; Providing temporary use of online non-downloadable computer software for medical treatment, namely, for digital therapeutics; Providing temporary use of online non-downloadable computer software for medical testing and diagnostics; Design, development and maintenance of computer application software for medical treatment; Design, development and maintenance of computer application software for medical testing and diagnostics

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Aug 8, 2023 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Jul 6, 2023 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 5, 2023 APRE
TEAS SECTION 7 REQUEST RECEIVED
Dec 27, 2022 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 27, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 11, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 11, 2022 PUBO
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 28, 2022 ASCK
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 21, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Sep 6, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 2, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2022 CNSA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 3, 2022 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 3, 2022 PARI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 3, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 3, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2022 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 7, 2022 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 20, 2021 RCCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 30, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 30, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 30, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 25, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 25, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 25, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2021 CRFA
ASSIGNED TO LIE
Feb 17, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2020 CNRT
TEAS VOLUNTARY AMENDMENT RECEIVED
May 28, 2020 PARI
ASSIGNED TO EXAMINER
May 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2020 NWOS
NEW APPLICATION ENTERED
May 12, 2020 NWAP